Cancer-associated venous thromboembolism

AA Khorana, N Mackman, A Falanga… - Nature reviews Disease …, 2022 - nature.com
Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial
events) is highly consequential for patients with cancer and is associated with worsened …

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

S Gritsch, TT Batchelor, LN Gonzalez Castro - Cancer, 2022 - Wiley Online Library
The 2016 revised fourth edition of the World Health Organization (WHO) classification of
central nervous system (CNS) tumors incorporated molecular features with histologic …

DNA methylation profiling: an emerging paradigm for cancer diagnosis

A Papanicolau-Sengos, K Aldape - Annual Review of Pathology …, 2022 - annualreviews.org
Histomorphology has been a mainstay of cancer diagnosis in anatomic pathology for many
years. DNA methylation profiling is an additional emerging tool that will serve as an adjunct …

Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update

BT Whitfield, JT Huse - Brain pathology, 2022 - Wiley Online Library
Over the last decade, developments in molecular profiling have radically altered the
diagnosis, classification, and management of numerous cancer types, with primary brain …

Cancer metabolism and tumor microenvironment: fostering each other?

Y Yuan, H Li, W Pu, L Chen, D Guo, H Jiang… - Science China Life …, 2022 - Springer
The changes associated with malignancy are not only in cancer cells but also in
environment in which cancer cells live. Metabolic reprogramming supports tumor cell high …

[HTML][HTML] Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System

T Komori - Laboratory Investigation, 2022 - Elsevier
The grading of gliomas based on histological features has been a subject of debate for
several decades. A consensus has not yet been reached because of technical limitations …

Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors

A Lauko, A Lo, MS Ahluwalia, JD Lathia - Seminars in cancer biology, 2022 - Elsevier
Brain tumors remain one of the most difficult tumors to treat and, depending on the
diagnosis, have a poor prognosis. Of brain tumors, glioblastoma (GBM) is the most common …

Molecular biomarker testing for the diagnosis of diffuse gliomas: guideline from the College of American Pathologists in collaboration with the American Association of …

DJ Brat, K Aldape, JA Bridge… - … of pathology & …, 2022 - meridian.allenpress.com
Context.—The diagnosis and clinical management of patients with diffuse gliomas (DGs)
have evolved rapidly over the past decade with the emergence of molecular biomarkers that …

[HTML][HTML] Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds

H Liu, W Qiu, T Sun, L Wang, C Du, Y Hu, W Liu… - … Pharmaceutica Sinica B, 2022 - Elsevier
Glioblastoma (GBM) is the most common aggressive malignant tumor in brain
neuroepithelial tumors and remains incurable. A variety of treatment options are currently …

MGMT and whole-genome DNA methylation impacts on diagnosis, prognosis and therapy of glioblastoma multiforme

R Della Monica, M Cuomo, M Buonaiuto… - International Journal of …, 2022 - mdpi.com
Epigenetic changes in DNA methylation contribute to the development of many diseases,
including cancer. In glioblastoma multiforme, the most prevalent primary brain cancer and …